What Are Teratogens? Causes, Types, and Effects

A teratogen is any agent that can disrupt normal embryonic or fetal development and cause a birth defect. The word comes from the Greek “teras,” meaning monster, and “gen,” meaning to produce, but the reality is far less dramatic and far more common than that etymology suggests. Teratogens include prescription medications, recreational drugs, infections, environmental chemicals, radiation, and even maternal health conditions like uncontrolled diabetes. What makes the subject both fascinating and unsettling is that timing, dose, and an individual’s genetic makeup all determine whether an exposure causes harm, meaning the same substance can be harmless to one pregnancy and devastating to another.

How Teratogens Reach the Developing Embryo

The placenta is often described as a “barrier,” but that framing is misleading. During pregnancy, many drugs and chemicals cross the placenta either by passive diffusion or through active transport proteins, directly exposing the fetus.¹ Small, fat-soluble molecules slip through easily. Larger molecules sometimes get ferried across by the same transporter proteins that deliver nutrients to the fetus. The placenta does metabolize some substances and slow their transfer, but it is porous enough that most drugs a pregnant person takes will reach the embryo in some concentration. That is why the question is rarely whether an exposure reaches the fetus but how much gets through and when.

The Critical Window That Changes Everything

The timing of exposure matters more than almost any other variable. The most vulnerable period for structural birth defects falls roughly between the third and sixth week of human development, which corresponds to about weeks five through eight of a standard pregnancy count from the last menstrual period.² This is the period of organogenesis, when the basic structures of the heart, brain, limbs, and face are being laid down. An exposure during this window can permanently alter how an organ forms. The same chemical hitting a few weeks earlier, before organ formation has begun, is more likely to either have no effect or cause a miscarriage. A few weeks later, once the structures are already in place, the risk shifts from malformations to growth problems or functional damage to the brain and other organs.

This timing reality creates a practical problem: many people do not know they are pregnant until they are already partway through that critical window. By the time a missed period prompts a pregnancy test, the embryo may already be four or five weeks into development. That gap is one reason public health guidance emphasizes preconception planning and why some medications carry warnings for anyone who could become pregnant, not just those who are.

The Thalidomide Disaster and the Birth of Modern Safety Testing

Before the late 1950s, there was little systematic testing of whether drugs could harm a developing fetus. That changed after thalidomide, a sedative prescribed to pregnant women for morning sickness, caused severe limb defects in thousands of children worldwide. The tragedy prompted regulatory agencies in the United States and internationally to develop systematic protocols for testing drugs for developmental toxicity before they could reach the market.³ It also reshaped the FDA itself, expanding requirements for informed consent, mandating greater transparency from drug manufacturers, and fundamentally changing how new drugs are evaluated for safety.⁴ Every modern drug label’s pregnancy section traces back, in some way, to the lessons forced by thalidomide.

Pharmaceutical Teratogens

Only a small fraction of all medications are proven teratogens, but the ones that are can cause serious harm. A few well-studied examples illustrate the range of effects.

Isotretinoin (Accutane)

Isotretinoin, prescribed for severe acne, is one of the most potent known teratogens. Infants exposed in the womb face an estimated 20 to 35 percent risk of birth defects, including craniofacial defects, cardiovascular malformations, neurological problems, and thymic disorders.⁵ Because of this, anyone prescribed isotretinoin in the United States must enroll in a risk-management program that requires pregnancy testing and the use of two forms of contraception. The drug’s mechanism relates to its powerful effect on retinoic acid signaling, a pathway that plays a central role in how embryonic tissues differentiate into specific organs.

Valproic Acid

Valproic acid, used to treat epilepsy and bipolar disorder, carries roughly a threefold increase in the rate of major birth defects compared with the general population.⁶ The risks are not limited to neural tube defects like spina bifida. A large registry-based study found significantly increased odds for spina bifida, cleft palate, heart defects, hypospadias, extra digits, and premature fusion of skull bones, with some of those risks elevated more than fivefold.⁷ Systematic reviews comparing valproic acid with other anti-seizure medications have consistently found it carries a higher teratogenic risk than the alternatives, with relative risks roughly two and a half times those of other antiepileptic drugs.⁸ For women with epilepsy, this creates a genuine dilemma: uncontrolled seizures during pregnancy carry their own risks, so stopping medication entirely is not always safe either. The decision involves weighing the specific drug’s teratogenic potential against the danger of the untreated condition.

Infections as Teratogens

The classic group of infectious teratogens goes by the acronym TORCH: toxoplasmosis, other infections, rubella, cytomegalovirus, and herpes simplex virus. These organisms can cross the placenta and directly infect the developing fetus, causing damage that ranges from hearing loss and vision problems to severe brain malformations. Rubella was one of the first infections recognized as a teratogen, after an Australian ophthalmologist in the 1940s linked an outbreak of rubella to a wave of congenital cataracts in newborns. Vaccination has made congenital rubella syndrome rare in countries with high immunization rates, but it remains a threat wherever vaccination coverage drops.

Zika virus provided a more recent example. During the 2015-2016 outbreak in the Americas, a systematic review concluded that Zika virus infection during pregnancy is a cause of congenital brain abnormalities, including microcephaly.⁹ Unlike rubella, no vaccine for Zika currently exists, so prevention relies on avoiding mosquito bites in affected regions. Zika underscored how quickly a previously obscure pathogen can emerge as a major teratogenic threat.

Alcohol and the Spectrum of Fetal Effects

Alcohol is the most common preventable cause of birth defects and developmental disabilities. Unlike most pharmaceutical teratogens, there is no well-established safe threshold for alcohol during pregnancy, which is why major health agencies recommend abstaining entirely. Children exposed prenatally can experience a range of outcomes collectively known as fetal alcohol spectrum disorders, or FASD, which include facial abnormalities, growth restriction, and brain damage. Imaging studies have detected differences in brain structure across multiple brain systems in affected children, along with abnormalities in the white matter connecting those regions. Levels of chemical messengers in the brain also appear to be altered, and brain-function studies reveal differences in working memory, learning, and impulse control.¹⁰

At the cellular level, there is growing evidence that prenatal alcohol exposure disrupts the migration of a specific type of brain cell, called inhibitory interneurons, that plays a critical role in cortical development.¹¹ When those cells do not end up where they need to be, the circuitry of the brain is permanently miswired. The result is not always visible at birth: many children with FASD have no obvious facial features and are diagnosed later, if at all, when learning difficulties or behavioral problems emerge.

Environmental Chemicals and Heavy Metals

Methylmercury

Methylmercury is the form of mercury most dangerous to a developing brain. It crosses the blood-brain barrier easily and accumulates in neural tissue, and fetuses are at particularly high risk.¹² The vulnerability gap between mother and child was strikingly illustrated during the Minamata disaster in Japan, where mercury-contaminated fish caused devastating neurological damage. In some cases, infants were born with severe congenital poisoning while their mothers showed only mild symptoms, demonstrating how uniquely susceptible the developing nervous system is.¹³ Today, the primary exposure route for most people is through consuming large predatory fish like swordfish, shark, and king mackerel, which is why dietary advisories for pregnant women focus on limiting those species while still encouraging fish consumption for its nutritional benefits.

Endocrine Disruptors

A growing area of concern involves chemicals that interfere with hormone signaling, often called endocrine disruptors. Bisphenols, found in some plastics and can linings, can alter the activity of enzymes involved in producing estrogen and progesterone in the placenta. Phthalates, used as plasticizers in many consumer products, can impair placental development through effects on thyroid hormone receptors.¹⁴ A birth cohort study in New York City found that higher prenatal exposure to certain bisphenols and phthalates was associated with higher weight and body mass index in children through age four, suggesting these chemicals may influence metabolic programming before birth.¹⁵ The effects are subtle and play out over years rather than being visible at birth, which makes them harder to study and easier to overlook.

Physical Agents and Maternal Conditions

Fever and Hyperthermia

Elevated body temperature during early pregnancy is a teratogenic risk that often surprises people. A systematic review and series of meta-analyses found that fever during the first trimester was associated with a roughly 1.5 to nearly threefold increased risk of neural tube defects, congenital heart defects, and oral clefts.¹⁶ The effects appear to be dose- and timing-dependent, with proposed mechanisms including heat-induced cellular stress and immune activation that disrupts embryonic development.¹⁷ This is why pregnant women are generally advised to treat fevers promptly with acetaminophen (which is considered safer in pregnancy than ibuprofen or aspirin) and to avoid prolonged use of hot tubs or saunas during the first trimester.

Maternal Diabetes

Poorly controlled blood sugar during early pregnancy acts as a teratogen in its own right. High maternal glucose crosses the placenta, exposing the embryo to a hyperglycemic environment that triggers excessive insulin production in the fetus. The resulting oxidative stress damages cells during critical periods of organ formation, interfering with cellular signaling and DNA repair. In the context of neural tube development, this can prevent the neural tube from closing properly.¹⁸ Heart defects, kidney malformations, and skeletal abnormalities are also more common. The risk is substantially higher with preexisting diabetes than with gestational diabetes that develops later in pregnancy, precisely because the window for structural defects has often closed by the time gestational diabetes is typically diagnosed.

Paternal Exposures Matter Too

Teratology has historically focused almost entirely on the pregnant person, but a growing body of research shows that a father’s environmental exposures before conception can influence offspring health through changes to sperm. Lifestyle factors, pollutants, infections, and toxins can alter sperm through shifts in DNA methylation, modifications to the proteins that package DNA, and changes in the small RNA molecules that sperm carry.¹⁹ These changes have the potential to be passed to offspring and affect how genes are expressed in the next generation.²⁰

Some of the evidence is strikingly specific. A study of fathers exposed to air pollution found that high levels of fine particulate matter and nitrogen dioxide during the period of sperm production were associated with lower birthweight in their babies, with the effect mediated through changes in sperm DNA methylation at a growth-regulating gene.²¹ In animal research, paternal exposure to methotrexate, a chemotherapy drug, caused cranial cartilage defects in offspring, and injecting just the small RNA fraction from treated males’ sperm into normal fertilized eggs was enough to reproduce those defects.²² Even chronic stress in male mice has been linked to reduced levels of specific small RNA molecules in sperm, changes that persist through early embryo development. The same pattern of reduced sperm RNA levels has been observed in men who experienced early-life trauma.²³ This field is still young, and most of the strongest evidence comes from animal models, but it is reshaping the conversation about who should be thinking about preconception health.

Why Identical Exposures Cause Different Outcomes

One of the most puzzling aspects of teratology is that two pregnancies exposed to the same drug at the same dose during the same developmental window can have completely different outcomes. Part of the explanation is genetic. Both the mother’s and the embryo’s genes influence how a substance is absorbed, metabolized, transported across the placenta, and received at its target, and variations in any of those steps can change whether the exposure causes harm.²⁴ A mother who metabolizes a drug quickly may produce lower fetal concentrations than one who metabolizes it slowly, even at the same dose. An embryo with a particular variant of a detoxification enzyme might handle the same exposure more effectively than one without it.

This genetic variability is one reason teratogenic risks are expressed as probabilities rather than certainties. When isotretinoin carries a 20 to 35 percent risk of birth defects, that means the majority of exposed pregnancies do not result in malformations, but there is no way to predict in advance which ones will. The same logic applies more broadly: a finding that a drug triples the risk of a specific defect sounds alarming, but if the baseline risk is very low, even a tripled risk remains relatively small in absolute terms. Understanding this distinction between relative and absolute risk is one of the more empowering things you can learn about teratogens.

Prevention Through Folic Acid

Folic acid supplementation is the clearest success story in teratogen prevention. Folic acid plays a critical role in DNA synthesis and repair, and it is essential for rapidly dividing cells like those of a developing embryo. Low levels during early pregnancy interfere with these processes and increase the risk of neural tube defects like spina bifida.²⁵ Because the neural tube closes very early, around the fourth week of development, supplementation needs to start before pregnancy to be most effective. That is the reasoning behind the recommendation that anyone who could become pregnant take 400 micrograms of folic acid daily.

Recent research has begun to uncover why folic acid works at a molecular level. A study using fish embryos found that folic acid’s protective effect depends on an enzyme that links folate metabolism to retinoic acid signaling, a pathway critical for neural tube closure. Blocking this enzyme abolished folic acid’s ability to prevent neural tube defects, while restoring it brought the protection back.²⁶ If confirmed in humans, this could open the door to more targeted prevention strategies for pregnancies where standard folic acid supplementation falls short.

How Drug Safety in Pregnancy Is Classified

If you have ever looked up a medication and pregnancy, you may have encountered the old letter categories: A, B, C, D, and X. The FDA retired that system in 2015 and replaced it with narrative descriptions of what is actually known about a drug’s risk during pregnancy and breastfeeding.²⁷ The old letter grades were misleading. Many people assumed “Category B” meant a drug was safe, when it often just meant that animal studies showed no harm but no human data existed. The new labeling rule requires a narrative summary that describes the actual evidence, clinical considerations, and background data for each drug.²⁸ In practice, this means labels are more informative but also longer and harder to interpret without help from a clinician.

Beyond Visible Birth Defects

Not all teratogenic damage is visible at birth. The field of behavioral teratology studies how prenatal exposures alter brain development in ways that show up months or years later as learning difficulties, behavioral problems, or psychiatric disorders.²⁹ Fetal alcohol spectrum disorders are the most well-known example, but the pattern extends to other exposures as well.

Cannabis provides an instructive case. Longitudinal studies tracking children exposed to cannabis in the womb have found that standard IQ scores are not affected, but measures of attention, visual analysis, and executive function are. The findings suggest prenatal cannabis exposure selectively harms aspects of higher-order thinking that depend on the prefrontal cortex, a brain region that matures late and is particularly vulnerable during development.³⁰ These deficits are subtle enough that they may never be traced back to the prenatal exposure unless someone is specifically looking, which makes behavioral teratology both harder to study and easier to dismiss.

Hyperthermia during pregnancy has also been linked to neurodevelopmental effects beyond structural malformations. Research suggests that elevated temperature alone may harm central nervous system development and has been associated with behavioral conditions in offspring.³¹ These findings reinforce that the brain’s sensitivity to teratogenic insult extends well beyond the narrow window for visible structural defects.

Prenatal Screening and Modern Detection

Advances in ultrasound technology have made it possible to detect many teratogen-induced malformations earlier in pregnancy. High-resolution imaging can now identify structural abnormalities during the first trimester, shifting prenatal diagnosis to the earliest possible point.³² For high-risk pregnancies, such as those involving known teratogenic exposures, early ultrasound can either provide reassurance that development appears normal or, when a serious malformation is detected, allow for informed decision-making and planning. Newer technologies like placenta-on-a-chip models are being developed to test how drugs cross the placental barrier without exposing real pregnancies, though these are still primarily research tools.³³ The long-term hope is that such systems could eventually reduce the need for animal testing while giving more reliable predictions of human placental transfer than current methods provide.